1. INTRODUCTION

1.1. RESEARCH OBJECTIVES

1.2. RESEARCH METHODOLOGY

1.3. RESEARCH PROCESS

1.4. SCOPE AND COVERAGE

1.4.1. Market Definition

1.4.2. Key Questions Answered

1.5. MARKET SEGMENTATION

2. EXECUTIVE SUMMARY

3. MARKET OVERVIEW

4. GROWTH OPPORTUNITIES BY SEGMENT

5. MARKET LANDSCAPE

5.1. PORTER’S FIVE FORCES ANALYSIS

5.1.1. Bargaining Power Of Supplier

5.1.2. Threat Of New Entrants

5.1.3. Threat Of Substitutes

5.1.4. Competitive Rivalry

5.1.5. Bargaining Power Among Buyers

5.2. INDUSTRY VALUE CHAIN ANALYSIS

5.3. MARKET DYNAMICS

5.3.1. Drivers

5.3.2. Restraints

5.3.3. Opportunities

5.3.4. Challenges

5.4. MARKET TREND ANALYSIS

5.5. REGULATORY LANDSCAPE

5.6. PESTLE ANALYSIS

5.7. PRICE TREND ANALYSIS

5.8. PATENT ANALYSIS

5.9. PRODUCT EVALUATION

5.10. MARKET IMPACT OF THE RUSSIA-UKRAINE WAR

5.10.1. Geopolitical Market Disruptions

5.10.2. Supply Chain Disruptions

5.10.3. Instability in Emerging Markets

5.11. ECOSYSTEM

6. BIODEFENCE MARKET BY PRODUCT (2023-2033)

6.1. BIODEFENCE MARKET SNAPSHOT AND GROWTH ENGINE

6.2. MARKET OVERVIEW

6.3. ANTHRAX

6.3.1. Introduction And Market Overview

6.3.2. Historic And Forecasted Market Size in Value (2023-2033F)

6.3.3. Historic And Forecasted Market Size in Volume (2023-2033F)

6.3.4. Key Market Trends, Growth Factors And Opportunities

6.3.5. Geographic Segmentation Analysis

6.4. BOTULISM

6.5. SMALLPOX

6.6. RADIATION/NUCLEAR

6.7. OTHER PRODUCTS

7. BIODEFENCE MARKET BY END-USER (2023-2033)

7.1. BIODEFENCE MARKET SNAPSHOT AND GROWTH ENGINE

7.2. MARKET OVERVIEW

7.3. HOSPITALS & CLINICS

7.3.1. Introduction And Market Overview

7.3.2. Historic And Forecasted Market Size in Value (2023-2033F)

7.3.3. Historic And Forecasted Market Size in Volume (2023-2033F)

7.3.4. Key Market Trends, Growth Factors And Opportunities

7.3.5. Geographic Segmentation Analysis

7.4. AMBULATORY CARE CENTERS

7.5. OTHER END-USERS

8. COMPANY PROFILES AND COMPETITIVE ANALYSIS

8.1. COMPETITIVE LANDSCAPE

8.1.1. Competitive Benchmarking

8.1.2. BIODEFENCE MARKET Share By Manufacturer (2023)

8.1.3. Industry BCG Matrix

8.1.4. Heat Map Analysis

8.1.5. Mergers & Acquisitions

8.2. ALTIMMUNE INC.

8.2.1. Company Overview

8.2.2. Key Executives

8.2.3. Company Snapshot

8.2.4. Role of the Company in the Market

8.2.5. Sustainability and Social Responsibility

8.2.6. Operating Business Segments

8.2.7. Product Portfolio

8.2.8. Business Performance (Production Volume, Sales Volume, Sales Margin, Production Capacity, Capacity Utilization Rate)

8.2.9. Key Strategic Moves And Recent Developments

8.2.10. SWOT Analysis

8.3. XOMA CORPORATION

8.4. DYNAVAX TECHNOLOGIES CORPORATION

8.5. EMERGENT BIOSOLUTIONS INC.

8.6. SIGA TECHNOLOGIES

8.7. ALNYLAM PHARMACEUTICALS INC.

8.8. ICHOR MEDICAL SYSTEMS

8.9. ELUSYS THERAPEUTICS INC.

8.10. DYNPORT VACCINE COMPANY

8.11. BAVARIAN NORDIC

8.12. CLEVELAND BIOLABS

8.13. OLOGY BIOSERVICES

8.14. OTHER KEY PLAYERS

9. GLOBAL BIODEFENCE MARKET BY REGION

9.1. OVERVIEW

9.2. NORTH AMERICA

9.2.1. Key Market Trends, Growth Factors And Opportunities

9.2.2. Key Manufacturers

9.2.3. Historic And Forecasted Market Size By PRODUCT

9.2.4. Historic And Forecasted Market Size By END-USER

9.2.5. Historic And Forecasted Market Size By Country

9.2.5.1. USA

9.2.5.2. Canada

9.2.5.3. Mexico

9.3. EASTERN EUROPE

9.3.1. Key Market Trends, Growth Factors And Opportunities

9.3.2. Key Manufacturers

9.3.3. Historic And Forecasted Market Size By Segments

9.3.4. Historic And Forecasted Market Size By Country

9.3.4.1. Russia

9.3.4.2. Bulgaria

9.3.4.3. The Czech Republic

9.3.4.4. Hungary

9.3.4.5. Poland

9.3.4.6. Romania

9.3.4.7. Rest Of Eastern Europe

9.4. WESTERN EUROPE

9.4.1. Key Market Trends, Growth Factors And Opportunities

9.4.2. Key Manufacturers

9.4.3. Historic And Forecasted Market Size By Segments

9.4.4. Historic And Forecasted Market Size By Country

9.4.4.1. Germany

9.4.4.2. United Kingdom

9.4.4.3. France

9.4.4.4. The Netherlands

9.4.4.5. Italy

9.4.4.6. Spain

9.4.4.7. Rest Of Western Europe

9.5. ASIA PACIFIC

9.5.1. Key Market Trends, Growth Factors And Opportunities

9.5.2. Key Manufacturers

9.5.3. Historic And Forecasted Market Size By Segments

9.5.4. Historic And Forecasted Market Size By Country

9.5.4.1. China

9.5.4.2. India

9.5.4.3. Japan

9.5.4.4. South Korea

9.5.4.5. Malaysia

9.5.4.6. Thailand

9.5.4.7. Vietnam

9.5.4.8. The Philippines

9.5.4.9. Australia

9.5.4.10. New-Zealand

9.5.4.11. Rest Of APAC

9.6. MIDDLE EAST & AFRICA

9.6.1. Key Market Trends, Growth Factors And Opportunities

9.6.2. Key Manufacturers

9.6.3. Historic And Forecasted Market Size By Segments

9.6.4. Historic And Forecasted Market Size By Country

9.6.4.1. Turkey

9.6.4.2. Bahrain

9.6.4.3. Kuwait

9.6.4.4. Saudi Arabia

9.6.4.5. Qatar

9.6.4.6. UAE

9.6.4.7. Israel

9.6.4.8. South Africa

9.7. SOUTH AMERICA

9.7.1. Key Market Trends, Growth Factors And Opportunities

9.7.2. Key Manufacturers

9.7.3. Historic And Forecasted Market Size By Segments

9.7.4. Historic And Forecasted Market Size By Country

9.7.4.1. Brazil

9.7.4.2. Argentina

9.7.4.3. Rest of South America

10. INVESTMENT ANALYSIS

11. ANALYST VIEWPOINT AND CONCLUSION

11.1. Recommendations and Concluding Analysis

11.2. Potential Market Strategies

Report	Biodefence Market
Selected License	Multi ID: IMR1302

Buyer Information

Order Summary